Funding Opportunities

• Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21)
  (PA-17-323)
  National Human Genome Research Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Cancer Institute
  National Institute of Environmental Health Sciences
  National Institute of Neurological Disorders and Stroke
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03)
  (PA-17-324)
  National Human Genome Research Institute
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Cancer Institute
  National Institute of Environmental Health Sciences
  John E. Fogarty International Center
  Application Receipt Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01)
  (PA-17-325)
  National Human Genome Research Institute
  National Institute on Aging
  National Cancer Institute
  National Institute of Environmental Health Sciences
  National Institute of Neurological Disorders and Stroke
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Development of a Device to Objectively Measure Pain (R43/R44)
  (RFA-DA-18-012)
  National Institute on Drug Abuse
  Application Receipt Date(s): December 5, 2017), by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Development of a Device to Objectively Measure Pain (R41/R42)
  (RFA-DA-18-013)
  National Institute on Drug Abuse
  Application Receipt Date(s): December 5, 2017), by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Preparing for Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U01)
  (RFA-HL-18-018)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): October 31, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Increasing Use of Cardiac and Pulmonary Rehabilitation in Traditional and Community Settings (R61/R33)
  (RFA-HL-18-019)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): October 19, 2017 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Consortium Linking Oncology with Thrombosis (CLOT) (U01)
  (RFA-HL-18-021)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): October 23, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date . Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.